Crown Laboratories and Revance Therapeutics are set to merge, creating a major player in aesthetics and skincare. This merger, valued at $924 million, will combine their product lines, including DAXXIFY® and the RHA® Collection....
Read MoreCarisma Therapeutics has expanded its collaboration with Moderna to develop in vivo CAR-M therapies targeting autoimmune diseases. Building on successful preclinical research in oncology, Carisma’s proprietary chimeric...
Read MoreSOPHiA GENETICS, a cloud-native healthcare technology leader, has partnered with AstraZeneca to accelerate the global deployment of the liquid biopsy test, MSK-ACCESS®, powered by SOPHiA DDM™. This initiative aims to make liquid...
Read More
Laminate Medical Technologies’ VasQ™ extravascular support device, designed to enhance...
Read MoreFemasys has received FDA 510(k) clearance for its FemChec diagnostic device, designed to assess fallopian tubal status. The FemChec device provides controlled delivery of contrast media by alternating between saline and air to...
Read More